Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today ...

About Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals ... and delivering life-changing therapeutics. We are advancing an ion channel product portfolio to address areas of high unmet medical ...

A live audio webcast of the company presentation will be available on the "Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject ...

Early-Stage Pipeline: Next Generation Ion Channel Modulators Xenon continues to expand its portfolio by leveraging its extensive expertise to discover and develop potassium and sodium channel ...

Inspired by NASA aerospace engineering, this project features a plasma thruster, designed to maximize efficiency and increase ...

- Phase 3 topline data from azetukalner FOS epilepsy program planned for H2 2025 in support of NDA filing and potential commercial launch - First of three planned Phase 3 azetukalner MDD studies ...

These results suggest that similar reactions between helium and iron may have occurred within Earth’s core shortly after its formation, trapping much of the primordial helium-3 in the material that ...